Recent Results from the Largest European Impella® Registry
The Impact of Extensive Revascularization in Protected PCI and Impella Support in Cardiogenic Shock Treatment
The results of the R-IMP IT (Revascularization Extent in Impella Italian Registry) study were presented by Cristina Aurigemma, MD, PhD (Policlinico Gemelli, Rome) as part of e-PCR 2020. It's a subanalysis of the IMP-IT Registry (Impella Italian Registry) that was presented in the Late Breaking Clinical Trial Session at the EuroPCR in 2019 by Dr. Alaide Chieffo and published in EuroIntervention in 2020. Armin Klesius, MD, PhD, MBA recently spoke with Cristina Aurigemma MD, PhD, Professor Francesco Burzotta, MD, PhD, and Professor Carlo Trani, MD about the background, details and importance of this data in clinical practice.
To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: abiomed.com/important-safety-information